Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be downloaded here. The global equity market continued its rally in May, driven by accelerating AI infrastructure spending and a stronger-than-expected earnings season. The Fund (Platform Class) returned 2.1%, underperforming the MSCI World ex-Australia Index’s 4.5% return in May 2026. Information Technology holdings drove the positive return in the month, along with modest contributions from Health Care and Consumer Discretionary exposures. However, the portfolio underperformed compared to the benchmark, primarily due to the high returns from the benchmark’s mega-cap technology and semiconductor stocks. In addition, please check the Strategy’s top five holdings to know its best picks in 2026.
In its May 2026 investor letter, Bell Global Equities Fund highlighted Stryker Corporation (NYSE:SYK) as a newly added position. Stryker Corporation (NYSE:SYK) is a US-based medical technology company that operates through its MedSurg, Neurotechnology, and Orthopaedics segments. On July 8, 2026, Stryker Corporation (NYSE:SYK) closed at $326.85 per share, reflecting a market capitalization of $126.11 billion. Stryker Corporation (NYSE:SYK) posted a one-month return of 7.22%, while its shares lost 16.99% over the past 52 weeks.
Bell Global Equities Fund stated the following regarding Stryker Corporation (NYSE:SYK) in its May 2026 investor update:
“We also established a position in Stryker Corporation (NYSE:SYK), the US-based global medical technology leader specialising in reconstructive implants, medical and surgical equipment, and neurotechnology products. Stryker possesses many of the quality characteristics we seek: a best-in-class management team with a strong record of execution, a decentralised operating model that has consistently delivered organic revenue growth ahead of large-cap medtech peers, and durable competitive advantages anchored by the Mako robotics platform, which effectively locks hospitals into Stryker’s implant consumables once installed and continues to expand into new applications such as spine and shoulder. The opportunity to initiate arose from a combination of the broader medtech de-rating and stock-specific weakness following a March cyberattack that temporarily disrupted the company’s manufacturing, ordering and shipping operations, with the shares falling to 52 week lows after the company’s first quarter result quantified the disruption. Importantly, we view the impact as transitory rather than structural: underlying procedure volumes held steady through the disruption, the order book remains elevated, and management maintained its full-year organic sales growth guidance of 8 to 9.5%, with the majority of delayed sales expected to be recouped over the remainder of 2026. With the forward P/E multiple having compressed to approximately 19x from the 25 to 30x range a year earlier, we saw an attractive entry point into a high-quality compounder at a meaningful discount to its history and relative to its quality and growth characteristics.”
Stryker Corporation (NYSE:SYK) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 81 hedge fund portfolios held Stryker Corporation (NYSE:SYK) at the end of the first quarter, up from 67 in the previous quarter. While we acknowledge the risk and potential of Stryker Corporation (NYSE:SYK) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Stryker Corporation (NYSE:SYK) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Stryker Corporation (NYSE:SYK) and shared the list of best robotics stocks to buy as Amazon deploys 1 million robots. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
